Published 13 May 2020
Introduction
In recent weeks, at least seven class action lawsuits have
been filed in federal district courts throughout the United
States against the government of the People's Republic of China
(the "P.R.C." or "China"), all relating to China's alleged
liability for damages and injuries sustained in the ongoing
COVID-19 pandemic. Although plaintiffs in these lawsuits make
broadly different claims, they all face the same highly
formidable legal roadblock: a need to find exceptions that can
pierce the presumptive immunity afforded to China and other
sovereign nations under the Foreign Sovereign Immunities Act
("FSIA"), 28 U.S.C. § 1602, et seq., which would
otherwise preclude their claims at the outset for lack of
jurisdiction.
To read this article you need to be a subscriber
Subscribe
Fill in the registration form and answer a few simple questions to receive a quote.
Subscribe now
Suggested Citation
M. Diaz, Jr.; M. Colomar-Garcia; B.C. Hadaway; G.E. Davidson; X.J. Zhao; J. Coronado; Z. Pan (2020, forthcoming) "The Façade of COVID-19 Class Action Litigation Against China Under the Foreign Sovereign Immunities Act"
(TDM, ISSN 1875-4120) May 2020, www.transnational-dispute-management.com
Other recently published material:
Current Trends in the Investment Environmental Jurisprudence and Predictions for Investment Disputes Involving Climate Change
24 January 2023
Climate Change and the Territoriality of International Investment Agreements
20 January 2023
International Investment Arbitration and the Environment: In the Search for Coexistence
20 January 2023
Now available in TDM 6 (2022) - Prospects and Challenges of Issuance of Sukuk in Bangladesh: Lessons from Malaysia for Developing a Comprehensive Legal Framework for Bangladesh
19 January 2023
The Police Powers Doctrine: Balancing Regulatory Chill with Rising Temperatures
19 January 2023
Complete listing of Advance publication.